4.1 Article

Truncation of Plasmodium berghei merozoite surface protein 8 does not affect in vivo blood-stage development

Journal

MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Volume 159, Issue 1, Pages 69-72

Publisher

ELSEVIER
DOI: 10.1016/j.molbiopara.2008.01.005

Keywords

malaria; Plasmodium berghei; merozoite surface proteins; MSP8; gene knockout

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

Merozoite surface protein 8 (MSP8) has shown promise as a vaccine candidate in the Plasmodium yoelii rodent malaria model and has a proposed role in merozoite invasion of erythrocytes. However, the temporal expression and localisation of MSP8 are unusual for a merozoite antigen. Moreover, in Plasmodium falciparum the MSP8 gene could be disrupted with no apparent effect on in vitro growth. To address the in vivo function of full-length MSP8, we truncated MSP8 in the rodent parasite Plasmodium berghei. Pb Delta MSP8 disruptant parasites displayed a normal blood-stage growth rate but no increase in reticulocyte preference, a phenomenon observed in P. yoelii MSP8 vaccinated mice. Expression levels of erythrocyte surface antigens were similar in P. berghei wild-type and Pb Delta MSP8-infected erythrocytes, suggesting that a parasitophorous vacuole function for MSP8 does not involve global trafficking of such antigens. These data demonstrate that a full-length membrane-associated form of PbMSP8 is not essential for blood-stage growth. (C) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available